Helsinn Therapeutics (U.S.) Inc., Signs Co-Promotion Agreement for Cancer Therapeutic Zykadia® in the US
. Zykadia® (ceritinib) is an approved treatment for patients with metastatic non-small cell lung cancer (NSCLC) whose…
. Zykadia® (ceritinib) is an approved treatment for patients with metastatic non-small cell lung cancer (NSCLC) whose…
. - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter ended June 30, 2011. S…
The potential for improving the quality of life is the most important property of any hay fever medication for those aff…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced results from a Phase III study of QNAZETM (beclometha…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter ended September 30, 2010. T…
Sneezing and itching, congestion and a constantly runny nose along with watery, red and swollen eyes - especially in win…
Spring is in the air at last! Most of us look forward to the end of the cold dark winter months and all the delights of…
In the first six months of 2008, Nycomed's adjusted EBITDA increased by 4.9% to € 653.7 million compared to € 623.3 mill…
. - Adjusted EBITDA increases due to lower costs - Most home markets performed very well - Major advancements in US o…
. - Sepracor acquires exclusive development, marketing and commercialisation rights to the Ciclesonide franchise in the…